(Q39474743)

12 September 2017

Evaluation of histone deacetylase inhibitors as therapeutics for neurodegenerative diseases (English)

1 reference

12 September 2017

1 reference

Elisabetta Soragni

1

1 reference

12 September 2017

Chunping Xu

2

1 reference

12 September 2017

Andrew Cooper

3

1 reference

12 September 2017

Heather L Plasterer

4

1 reference

12 September 2017

James R Rusche

5

1 reference

12 September 2017

Joel M Gottesfeld

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

Methods in Molecular Biology

12 September 2017

1 reference

12 September 2017

793

1 reference

12 September 2017

495-508

1 reference

describes a project that uses

12 September 2017

ImageQuant

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3548622/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3548622/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548622

Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencing

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548622

The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548622

Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548622

HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548622

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548622

Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548622

Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548622

10.1007/978-1-61779-328-8_32

17 June 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference

12 September 2017

PubMed publication ID

21913121

1 reference